Now more than 70% sold out- Why would any serious value investor miss a free ticket for Britain's Buffett vs Paul Scott at UK Investor on April 21?
The February 2018 edition of the UK Investor Show Magazine is now live: Nine share tips, giving in a tax-efficient way, don't count Trump out
Shocking Expose - The training video they used at UK Oil & Gas that made Steve Sanderson such a guru in investor relations
Published 249 days ago
The house broker on AIM earns its money not from investors but from corporates. It banks £2-4,000 a month as a retainer and then makes 5% commission on any funds it raises. Lovely jubbly, coke and hookers all round. Of course that makes its research less than impartial. Prostitutes do not tell their clients that they have a small dick and so you would not expect Arden Partners to conclude that shares in Mercantile Ports & Logistics (MPL) are worthless crap, which they are. Welcome to a strong contender for the worst research note of the year to date.
Published 261 days ago
Beaufort Securities acts as house broker to Solo Oil (SOLO) so it is paid to write research on the company. Think of the relationship as being like that as between a hooker and a punter. The punter pays the bills. The hooker assures him that he is hung like a donkey. With that minor caveat I bring you a fairly detailed note from research analyst Charles Long at Beaufort out today. Apparently the shares, now 0.24p are worth 0.91p. But Hang on Henry...
Published 274 days ago
AIM-listed CyanConnode – Cyan to its friends – (CYAN) again looks set for a fair ride the wrong way after Beaufort Securities drew the red pen to its speculative buy note. It is now flat – a plain hold – which to normal people means sell. Of course, Beaufort was until recently a broker to the company, but that obviously has nothing to do with it. Beaufort states:
Published 395 days ago
The fragrant Alice Lane, a foxy young brokerette who apparently I once reduced to tears by being so beastly, is this morning disseminating the latest FinnCap note on Premaitha (NIPT) to clients. Since it is bullish I am happy to make it up to Alice by exposing this high quality research to a wider audience, especially since we own more than a few shares. By way of balance i should say that FinnCap is house broker and therefore utterly partial and you can feel free to ignore every word of this report.
Published 418 days ago
This is becoming something of a ritual. Advanced Oncotherapy (AVO) is tardy in releasing very bad news but eventually fesses up. But it misleads investors. Its (now very clearly former) partner Sinophi then, effectively, accuses it of lying. Oh dear, for the second time Sinophi has stated that (almost insolvent) Advanced is telling porkies.
Published 462 days ago
It is now 11 days since I published details of leaked emails which showed that AIM scumbag Advanced Oncotherapy had withheld awful trading news from investors as the company launched an open offer. That is clearly securities fraud. Almost as bad, the emails showed that the timelines the company had held out to both customers in China and investors in London for product delivery were just fantasy. And that is why customers walked. Heads should have rolled. Hapless Nomad Stockdale should have forced a statement. And having told its house broker (Beaufort) that a much needed refinancing would happen by the year end, we need an update on that too. Instead...
Published 467 days ago
Time is running out for Advanced Oncotherapy (AVO) as it scrabbles for additional finance but this time it really needs to start telling the truth to potential backers. In fact before I reveal more leaked emails I invite it to correct some previous lies told now.
Published 510 days ago
This website has pointed out that AIM listed IGAS has been a slam dunk sell for more than two years but for a good few months as it warned that it would breach covenants on its bonds any moron could see that the writing was on the wall. Except loyal house broker Cannacord, shamed over the Quindell fraud, its research on this has been laughable. It shows that a buy note from a house broker, especially one as shoddy as Cannacord, is just worthless. You will remember how Canaccord fired heroic Kevin Ashton, the world's number 1 tech analyst, when he refused to write a buy note on the Quindell fraud.
Published 1004 days ago
Panmure Gordon is house broker to Premaitha (NIPT) so take its morning note with a pinch of salt. It is paid to say buy. However for what it is worth here is its analysis of today's news and its forecasts.
Published 1025 days ago
Hybridan is house broker to Optibiotix (OPTI) and so its views can be largely ignored.It is paid to be bullish. But by way of background here is its post results commentary which we happen to agree with. Busted clocks and all of that.
Published 1248 days ago
Shares in recruitment software group Dillistone (DSG) have slipped back from more than 110p in July and in excess of 100p for most of last month to a current 96.5p. The company’s house broker, WH Ireland, has now updated and the following updates my view.
Published 1415 days ago
In the interests of balance I report to you the pre-results “buy” note on blinkx (BLNX) from its house broker Citi. It has a target price of 175p.. The shares are now 86p. However….
Published 1795 days ago
Oh please. I am still laughing. You could not make this up. Well you could. Circle Oil (COP) has today appointed a new director Dr Keith Morris. Yes the name rings a bell. This is a scream.